Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
"Over the past year, we have reached an important inflection point. We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical ...
An Alley Oop is a cooperative move you can do in Practical Basketball. You can only perform it with a teammate, and it's a great way to score a point against the opposing team. It requires both ...
After 37 years, Frank Bennett is retiring from Ionis Pharmaceuticals. Bennett started at Ionis as a founding scientist in 1989 and climbed to the role of CSO. Bennett will retire in ...
This project is a comprehensive demonstration of all key Object-Oriented Programming (OOP) concepts learned throughout the Java OOP course (SIS2024Y). It serves as a complete portfolio piece ...
Minecraft's Java Edition has long been the go-to for PC players, owing to how moddable it is in comparison to its Bedrock counterpart. However, getting a clean multiplayer experience has long ...
Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...
Over the years, graveyard decks have, appropriately enough, proved to be some of the most enduringly popular strategies in Magic. There’s just something innately appealing about leveraging spent ...
Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results